期刊
INTERNATIONAL JOURNAL OF ONCOLOGY
卷 44, 期 4, 页码 1001-1014出版社
SPANDIDOS PUBL LTD
DOI: 10.3892/ijo.2014.2267
关键词
galectin; cancer; subcellular localization
类别
资金
- National Science and Engineering Research Council of Canada (NSERC)
- Fonds de la Recherche du Quebec-Sante (FRQS)
Dysregulation of galectin expression is frequently observed in cancer tissues. Such an abnormal expression pattern often correlates with aggressiveness and relapse in many types of cancer. Because galectins have the ability to modulate functions that are important for cell survival, migration and metastasis, they also represent attractive targets for cancer therapy. This has been well-exploited for extracellular galectins, which bind glycoconjugates expressed on the surface of cancer cells. Although the existence of intracellular functions of galectins has been known for many years, an increasing number of studies indicate that these proteins can also alter tumor progression through their interaction with intracellular ligands. In fact, in some instances, the interactions of galectins with their intracellular ligands seem to occur independently of their carbohydrate recognition domain. Such findings call for a change in the basic assumptions, or paradigms, concerning the activity of galectins in cancer and may force us to revisit our strategies to develop galectin antagonists for the treatment of cancer.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据